Partner Charities

Words about how we like to work with other charities - better together etc.

Latest

Santhera’s Raxone® Receives First Positive EAMS Scientific Opinion from UK’s MHRA in Duchenne Muscular Dystrophy

Duchenne UK is pleased to share news from Santhera Pharmaceuticals regarding the progress of Raxone. MHRA has granted Raxone a positive scientific opinion through the EAMS.
Welcome To Duchenne UK

Duchenne Children's Trust and Joining Jack have joined forces to create Duchenne UK, dedicated to funding and accelerating treatments for Duchenne Muscular Dystrophy.
Duchenne UK launches the INNOVATE grant call, worth up to £1million

Duchenne UK is pleased to announce the launch of its ‘Innovate’ Grant Call, and invites proposals for funding projects up to £1million, dedicated to finding new treatments for Duchenne muscular dystrophy (DMD).
Duchenne UK launches the INNOVATE grant call, worth up to £1million

Duchenne UK is pleased to announce the launch of its ‘Innovate’ Grant Call, and invites proposals for funding projects up to £1million, dedicated to finding new treatments for Duchenne muscular dystrophy (DMD).

Most read

The Impact Of Brexit On Rare Diseases

Please read and share our paper on the impact of Brexit on rare diseases.
Duchenne Dash 2017

London to Paris in 24 hours, by bike! We are now full for 2017 but please contact us to register interest for 2018 dash@duchenneuk.org
Understand Duchenne

Find out more about DMD and how we can help you
Meet The Team

Our Management team and Board of Trustees
Welcome To Duchenne UK

Duchenne Children's Trust and Joining Jack have joined forces to create Duchenne UK, dedicated to funding and accelerating treatments for Duchenne Muscular Dystrophy.
Our Strategy To End Duchenne

Learn more about the work we are doing
World's Strongest Boys

Help save the World's Strongest Boys
Patient Advisory Board

Patient and parent involvement is at the heart of Duchenne UK
How You Can Help

Join Us to End Duchenne
Vamorolone (VBP15) – Clinical trial recruitment has begun

ReveraGen are recruiting for the clinical trial for Vamorolone which could offer a potential alternative to steroids

Patient Advisory Board

Patient and parent involvement is at the heart of Duchenne UK Read more

Our Strategy To End Duchenne

Learn more about the work we are doing Read more

How You Can Help

Join Us to End Duchenne Read more

Our Impact

How we are making a difference Read more

Accelerating Potential Treatments for DMD

We fund a vital study into a combination of existing medicines for treating DMD Read more